Navigation Links
CardioDx Completes Validation Study of First-Of-Its-Kind Genomic Test for Coronary Artery Disease
Date:8/25/2009

sease affects tens of millions of Americans each year and is the leading cause of death in the United States. Coronary artery disease (CAD) is a narrowing or blockage of the coronary arteries (the major blood vessels that supply the heart with blood, oxygen and nutrients) that reduces blood flow to the heart muscle. As a result of the blockage, the heart does not get enough oxygenated blood, which can often cause chest pain (angina), shortness of breath and other symptoms. A severe blockage can cause a heart attack (myocardial infarction) or even death; one of every five deaths among Americans is caused by CAD. In 2008, CAD had an estimated direct and indirect cost of over $165 billion.

About CardioDx

CardioDx is a cardiovascular genomic diagnostics company providing physicians with clinically validated tests to enable more informed and individualized patient care decisions. We are strategically focused on developing products for three forms of cardiovascular disease: coronary artery disease (CAD), cardiac arrhythmias and heart failure. The company's first product, Corus(TM) CAD, is the first and only gene expression test to quantify the likelihood of obstructive coronary artery disease in a stable chest pain patient. Developed and validated in a multicenter U.S. clinical trial, Corus CAD integrates the activity of a panel of genes with other patient characteristics to assess obstructive coronary artery disease. Corus CAD is now available in nine states - Kentucky, Maryland, Illinois, Washington, Wisconsin, Minnesota, North Carolina, Texas and Arizona - via the CardioDx CLIA-certified Commercial Laboratory with broader availability expected in 2010. CardioDx was founded in 2004 and is located in Palo Alto, California. For more information, please visit www.cardiodx.com.

(1) Obstructive CAD is defined as at least
'/>"/>

SOURCE CardioDx
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
7. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
8. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
9. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
10. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 1, 2015 Following yesterday,s release of ... D, here are five things you need to know: ... market-based structure is unique among government programs. ... D is different than other parts of Medicare and other ... that submit bids to offer prescription drug benefits to enrollees. ...
(Date:5/1/2015)... , May 1, 2015  Portal Instruments, Inc., an ... systems, announced today that Robert Langer, Sc. D., ... University of Auckland Distinguished Professor have joined the company,s ... welcome two esteemed biotechnology leaders, Professor Robert Langer ... team," said Dr. Patrick Anquetil , Chief Executive ...
(Date:5/1/2015)... Heska Corporation (NASDAQ: HSKA - News ... veterinary diagnostic and other specialty veterinary products , today announced ... the 16th Annual B. Riley & Co. Investor Conference at ... be held May 12-14, 2015 at Lowes Hollywood Hotel, ... available during the day on May 13 for one-on-one meetings. ...
Breaking Medicine Technology:5 Things to Know About the CMS Part D Data Release 25 Things to Know About the CMS Part D Data Release 3Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 2Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 3Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 4Heska to Present at the 16th Annual B. Riley & Co. Investor Conference 2
... (AMS) (Nasdaq: AMMD ), a leading provider ... pelvic health, today announced the results of a six-month ... Prolapse Repair System. The pelvic organ prolapse quantification exam ... was implemented in the study and concluded efficacy rates ...
... March 10, 2011 Avaxia Biologics, Inc., a ... to develop orally-active antibody therapeutics for the treatment ... been awarded a Phase I Small Business Innovation ... Diabetes and Digestive and Kidney Diseases of the ...
Cached Medicine Technology:Six-Month Prospective Multi-Center Study Reports Efficacy Rates for AMS' Elevate Anterior and Apical Prolapse Repair System 2Avaxia Biologics Awarded Phase I SBIR Grant to Develop Oral Antibody Therapeutic for Celiac Disease 2
(Date:5/2/2015)... (PRWEB) May 03, 2015 As one ... of the prestigious Safety and Health Achievement and Recognition ... honored to be chosen by the Illinois Department of ... has achieved and maintained SHARP certification by the Occupational ... 2006, as Essentra has continued to meet or exceed ...
(Date:5/2/2015)... NY (PRWEB) May 02, 2015 It’s ... a deadly natural disaster strikes anywhere on this planet, ... leverage human sympathy and compassion for their own personal ... States Computer Emergency Readiness Team) issued an alert ... “of potential email scams citing the earthquake in Nepal. ...
(Date:5/2/2015)... 2015 As a nonsurgical staple ... the face, neck and décolleté, radiofrequency energy is ... potential for the success of vulvovaginal rejuvenation. In ... Advisory Council, ThermiGyn’s Women’s Health Clinical Advisory Board ... that ThermiGyn’s temperature controlled radio frequency, specifically that ...
(Date:5/1/2015)... May 01, 2015 Pioneer Millworks, the ... the latest in their reclaimed wood products at the ... Jacob Javits Center in NYC this May. Their newest ... bring much anticipated texture and color to North America's ... explosion of texture and color in the design world ...
(Date:5/1/2015)... 2015 It’s raining bills on Capitol Hill ... to expand federal support for telemedicine. , “Such ... been working with Congress,” said Jonathan Linkous, CEO of the ... nation is poised to embrace the use of telecommunications in ... in fulfilling ATA’s mission to improve quality, access, equity and ...
Breaking Medicine News(10 mins):Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2
... , ... email encryption provider, today announced that the company,s email encryption gateway now supports Red Hat ... www.djigzo.com . Djigzo can be installed using any of the provided packages for Ubuntu Linux, ... Workstation is available as well. , ...
... PRINCETON, N.J. , Jan. 13 A new ... $218 billion in 2007, with the exploding number of cases ... The National Changing Diabetes ® Program (NCDP), a program of ... article today in Health Affairs and performed by researchers ...
... ... onset of symptoms? One clever way to know for sure is to take snapshots of ... the patients over the years to see whether the diagnosis was correct. About 10 to ... , ...
... , WASHINGTON , Jan. ... issued the following statement today on a news ... largest insurance companies funneled between $10 million ... of Commerce to fund deceptive television ads opposing ...
... ... checks to their long list of services. ANY LAB TEST NOW® is a direct ... to Dallas residents. , ... January 12, 2009 -- ANY LAB TEST NOW® North Dallas announces web portal launch for providing ...
... , , BOSTON , Jan. 12 Americans ... in the Boston media market to educate Americans about ... $200,000 campaign, which will launch on Wednesday, January ... Americans for Responsible Heath Care television ads will remind the people ...
Cached Medicine News:Health News:Djigzo, an Open Source Email Encryption Provider, Today Announced That the Company's Encryption Gateway Now Supports Red Hat Linux 2Health News:Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates 2Health News:Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates 3Health News:Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates 4Health News:PET Scans May Help Diagnose Movement Disorders 2Health News:PET Scans May Help Diagnose Movement Disorders 3Health News:Pelosi: 'Insurance Industry Has Spent Millions of Dollars on Wrong Side of History' by Secretly Funding Deceptive Ads 2Health News:ANY LAB TEST NOW North Dallas Launches Web Portal for Background Checks 2Health News:Americans for Responsible Health Care Launch Ad Campaign in Massachusetts Senate Special Election Campaign 2
Formfit Ankle Stirrup with Foam Pads are Formfit Stirrup Ankle Braces with Revolutionary "Flex Edge" Technology....
... effective stirrup designed to truly function for both ... in profile than other stirrups, so it fits ... The X-Brace offers the Figure 8 X-Strap which ... foot. This allows the strapping of the midfoot ...
... fractures and Achilles ruptures are problem enough for ... of care and provide functional treatment for foot ... brings you the STORM. A combination of prefabricated ... freedom of movement with higher standards of safety. ...
... The Stabilizing Ankle support ... straps which lock the calcaneus ... abnormal eversion and inversion. The ... compression and stability. Ideal for ...
Medicine Products: